Skip to main content

Table 8 Univariate and multivariate analyses of the two groups

From: Correlation of catecholamine content and clinical influencing factors in depression among psoriasis patients: a case-control study

  The Psoriasis group The Control group P OR(95%CI) P’
Number, n 18 72    
Age (years) 48(44-67) 41(24-52) 0.005 0.954(0.895-1.017) 0.151
Sex, n(%) 13(72) 54 (75) 0.809 3.405(0.207-56.081) 0.391
Poor economic condition, n(%) 6(33%) 15(21) 0.262 0.344(0.021-5.701) 0.456
Family history, n(%) 6(33%) 9(13) 0.034 0.007(0.000-4.174) 0.128
Course of disease (month) 120(45-240) 72(6-120) 0.026 0.996(0.984-1.009) 0.556
AIS score 6(0-11) 1(0-9) 0.048 0.995(0.729-1.358) 0.977
PASI score 39(31-49) 29(18-37) 0.011 0.904(0.845-0.968) 0.004
DLQI score 11(10-17) 4(2-7) 0.000 0.601(0.429-0.842) 0.003
Dopamine (pg/ml) 50.15(47.01-51.43) 54.74(51.54-57.93) 0.000 1.448(1.033-2.029) 0.032
Norepinephrine (pg/ml) 149.22(140.05-158.83) 149.28(142.99-161.13) 0.928 1.002(0.913-1.101) 0.961
Epinephrine (pg/ml) 29.84(29.12-31.53) 31.78(29.17-34.30) 0.155 0.952(0.787-1.151) 0.611
  1. AIS Athens Insomnia Scale, PASI Psoriasis Area and Severity Index, DLQI Dermatology Life Quality Index